Mark Jackman

Mark Jackman is a Director in Biopharmaceutics, Business Development and Licensing at AstraZeneca, bringing over fifteen years of experience in the pharmaceutical industry. They have worked as a scientist on various drug delivery and small molecule R&D projects, managing complex multi-disciplinary collaborations from pre-clinical to late-stage development. Mark has been involved in strategy and capability building, with a strong passion for innovation and external collaboration. They hold a PhD in Nanotechnology from The University of Manchester and a degree in Chemistry from the University of York.